a month ago
CGEM
AnalystsJulian HarrisonJulian Harrison's Stock Forecasts
AnalystsJulian Harrison
Analyst Ranking
Top 5%
#250 out of 5548 analysts
Average Return
+21.67%
Win Rate
43%79 out of 185
Risk vs Reward
Poor
Good
Julian Harrison's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Spyre Therapeutics IncSYRE | +513.70% | $14.82 | $90.95 | 2025-09-16 - 2026-09-15 | Strong Buy |
Climb Bio IncCLYM | +487.93% | $2.32 | $13.64 | 2025-09-22 - 2026-09-21 | Strong Buy |
Oruka Therapeutics IncORKA | +477.11% | $16.21 | $93.55 | 2025-09-17 - 2026-09-16 | Strong Buy |
Climb Bio IncCLYM | +472.14% | $2.01 | $11.50 | 2025-09-30 - 2026-09-29 | Strong Buy |
Climb Bio IncCLYM | +459.49% | $1.95 | $10.91 | 2025-10-16 - 2026-10-15 | Strong Buy |
Julian Harrison Analyst Color
Get additional color on Julian Harrison's coverage of popular stocks
2 months ago
CLYM
3 months ago
CGEM
4 months ago
ABVX
4 months ago
SYRE
4 months ago
CLYM
5 months ago
RZLT
6 months ago
INVA
6 months ago
CLYM
6 months ago
AVTX
6 months ago
ORKA
6 months ago
SYRE
6 months ago
ORKA
7 months ago
JBIO
8 months ago
NKTR
9 months ago
ARDX
10 months ago
ABVX
10 months ago
APGE
10 months ago
APGE
a year ago
TBPH
a year ago
CGEM
a year ago
RNAC
a year ago
ORKA
a year ago
ABVX
a year ago
CLYM
Julian Harrison's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Avalo Therapeutics IncAVTX | 7 | Strong Buy | $10.00 | +44.30% | Maintains | a day ago |
Spyre Therapeutics IncSYRE | 14 | Strong Buy | $121.00 | +33.95% | Reiterates | 5 days ago |
Cullinan Therapeutics IncCGEM | 9 | Strong Buy | $40.00 | +178.36% | Reiterates | 5 days ago |
Oruka Therapeutics IncORKA | 11 | Strong Buy | $151.00 | +88.40% | Reiterates | 5 days ago |
Liquidia CorpLQDA | 12 | Strong Buy | $70.00 | +64.13% | Upgrades | 10 days ago |
Nektar TherapeuticsNKTR | 10 | Strong Buy | $178.00 | +378.24% | Reiterates | 15 days ago |
United Therapeutics CorpUTHR | 2 | Strong Buy | $728.00 | +23.91% | Upgrades | 23 days ago |
Connect Biopharma Holdings LtdCNTB | 6 | Strong Buy | $5.00 | +552.74% | Maintains | 24 days ago |
Maze Therapeutics IncMAZE | 8 | Strong Buy | $46.00 | +48.34% | Reiterates | a month ago |
Akebia Therapeutics IncAKBA | 6 | Strong Buy | $4.00 | +605.47% | Reiterates | a month ago |
Abivax SaABVX | 9 | Strong Buy | $175.00 | +98.84% | Reiterates | 2 months ago |
Climb Bio IncCLYM | 8 | Strong Buy | $32.00 | +214.03% | Maintains | 2 months ago |
Outlook Therapeutics IncOTLK | 8 | Strong Buy | $4.00 | +670.71% | Reiterates | 2 months ago |
Apogee Therapeutics IncAPGE | 8 | Hold | N/A | N/A | Downgrades | 2 months ago |
Mereo Biopharma Group PLCMREO | 5 | Strong Buy | $1.00 | +254.61% | Reiterates | 2 months ago |
Jade Biosciences IncJBIO | 8 | Strong Buy | $77.00 | +427.76% | Maintains | 2 months ago |
Ardelyx IncARDX | 4 | Strong Buy | $14.00 | +354.55% | Maintains | 3 months ago |
Yarrow Bioscience IncYARW | 2 | Strong Buy | $58.00 | +200.99% | Initiates Coverage On | 3 months ago |
Tvardi Therapeutics IncTVRD | 4 | Strong Buy | $5.00 | +431.91% | Maintains | 3 months ago |
Theravance Biopharma IncTBPH | 7 | Hold | N/A | N/A | Downgrades | 4 months ago |
Innoviva IncINVA | 5 | Strong Buy | $42.00 | +103.29% | Maintains | 4 months ago |
Cartesian Therapeutics IncRNAC | 3 | Strong Buy | $44.00 | +611.97% | Reiterates | 4 months ago |
Moonlake ImmunotherapeuticsMLTX | 7 | Strong Buy | $30.00 | +153.16% | Reiterates | 4 months ago |
Rezolute IncRZLT | 6 | Strong Buy | $6.00 | +55.64% | Maintains | 5 months ago |
Viridian Therapeutics IncVRDN | 4 | Strong Buy | $61.00 | +172.69% | Reiterates | a year ago |
Protagonist Therapeutics IncPTGX | 3 | Strong Buy | $82.00 | -40.76% | Reiterates | a year ago |
Keros Therapeutics IncKROS | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Anaptysbio IncANAB | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Aclaris Therapeutics IncACRS | 4 | Strong Buy | $8.00 | N/A | Upgrades | 2 years ago |
Cymabay Therapeutics IncCBAY | 8 | Hold | N/A | N/A | Downgrades | 3 years ago |
Matinas Biopharma Holdings IncMTNB | 1 | Strong Buy | $150.00 | N/A | Reinstates | 3 years ago |
Morphic Holding IncMORF | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Strong Buy | $181.00 | N/A | Maintains | 4 years ago |
Biora Therapeutics IncBIOR | 1 | Strong Buy | $4.00 | N/A | Assumes | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.